trending Market Intelligence /marketintelligence/en/news-insights/trending/hQ2WLaKJDnOxhMub_yWpLw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Report: 3M plans sale of drug delivery system unit

Street Talk Episode 61 - Investors debate if U.S. banks have enough capital in post COVID world

You Down With PPP? Consider The Risks

Street Talk Episode 60 - You Down With PPP? Consider The Risks

Gauging Supply Chain Risk In Volatile Times

Report: 3M plans sale of drug delivery system unit

U.S.-based 3M Co. is considering a sale of its drug delivery systems unit, which could fetch roughly $1 billion, Bloomberg News reported Dec. 6, citing people with knowledge of the matter.

The world's largest industrial conglomerate reportedly is working with an adviser to run an auction process for the unit, which makes products including asthma inhalers and skin patches.

The subsidiary is expected to draw interest from private equity firms, according to the report.

3M recently acquired medical technology company Acelity LP Inc. and global Kinetic Concepts Inc. subsidiaries for a total enterprise value of approximately $6.7 billion, including debt assumption and other adjustments.

A representative for 3M reportedly declined to comment.